Innovations in Oncology: An Interview with Raluca Budiu-Predoiu
“These are exciting times for all areas of oncology.” With new advances across the oncological board, from immuno-oncology and biomarkers, it is important to keep up with and understand the latest innovations. We spoke to Raluca Budiu-Predoiu, Translational Oncology Principal...
4 years agoInnovations in Oncology: An Interview with Raluca Budiu-Predoiu
“These are exciting times for all areas of oncology.” With new advances across the oncological board, from immuno-oncology and biomarkers, it is important to keep up with and understand the latest innovations. We spoke to Raluca Budiu-Predoiu, Translational Oncology Principal...
4 years ago
Broadening the Scope of Therapeutic Treatment – Advancements in Cancer Clinical Trials
With ground-breaking advancements in oncology like check-point inhibitors comes the extensive development of human clinical trials, prioritising patient safety and drug tolerability through pharmacovigilance. Proventa spoke to Chief Medical Officer for Xilio Therapeutics, Martin Huber, for his thoughts regarding exciting...
4 years agoBroadening the Scope of Therapeutic Treatment – Advancements in Cancer Clinical Trials
With ground-breaking advancements in oncology like check-point inhibitors comes the extensive development of human clinical trials, prioritising patient safety and drug tolerability through pharmacovigilance. Proventa spoke to Chief Medical Officer for Xilio Therapeutics, Martin Huber, for his thoughts regarding exciting...
4 years ago
Data Capture, Integration and Storage in Decentralised Trials
Decentralisation of virtual trials has grown rapidly during the COVID-19 pandemic, changing the nature of clinical trials for a number of large and small pharma companies. While this new way of conducting clinical operations promises to reduce costs and increase...
4 years agoData Capture, Integration and Storage in Decentralised Trials
Decentralisation of virtual trials has grown rapidly during the COVID-19 pandemic, changing the nature of clinical trials for a number of large and small pharma companies. While this new way of conducting clinical operations promises to reduce costs and increase...
4 years ago
The Promise of Quantum AI in Pharma R&D
Given the long-standing hype around AI and machine learning (ML) in pharma R&D, it can be easy to overlook innovations that potentially promise just as much for the pharmaceutical sector. Quantum computing is one area expected to have far-reaching impact...
4 years agoThe Promise of Quantum AI in Pharma R&D
Given the long-standing hype around AI and machine learning (ML) in pharma R&D, it can be easy to overlook innovations that potentially promise just as much for the pharmaceutical sector. Quantum computing is one area expected to have far-reaching impact...
4 years ago
A Look Ahead: Clinical Trials and PV Over the Next 5 Years
Given the severity of industry disruptions in 2020, and the surge in innovation and development that followed, the future of clinical operations seems more clouded than ever. Proventa set out to find out more about the future of Clinical Trials...
4 years agoA Look Ahead: Clinical Trials and PV Over the Next 5 Years
Given the severity of industry disruptions in 2020, and the surge in innovation and development that followed, the future of clinical operations seems more clouded than ever. Proventa set out to find out more about the future of Clinical Trials...
4 years ago
Weekly News Round-up – 29/1/21
In the news this week, the ongoing dispute between the UK and European Commission over vaccines entering the UK could lead to two months’ delay in herd immunity and thousands of deaths if EU plans go through. In other news,...
4 years agoWeekly News Round-up – 29/1/21
In the news this week, the ongoing dispute between the UK and European Commission over vaccines entering the UK could lead to two months’ delay in herd immunity and thousands of deaths if EU plans go through. In other news,...
4 years ago
Weekly News Round-up – 22/1/21
In the news this week, collaboration within the pharma industry continues to struggle as it is revealed that the WHO’s platform for industry collaboration over COVID-19 goes entirely unused. In other news, Merck finally loses its hepatitis C patent infringement...
4 years agoWeekly News Round-up – 22/1/21
In the news this week, collaboration within the pharma industry continues to struggle as it is revealed that the WHO’s platform for industry collaboration over COVID-19 goes entirely unused. In other news, Merck finally loses its hepatitis C patent infringement...
4 years ago
The Importance of Efficacy in COVID-19 Vaccines
With a number of competing vaccines rapidly rolling out around the world, for many COVID-19 seems an already receding issue. The leading vaccines - from AstraZeneca/University of Oxford, from Pfizer and from Moderna - are in the process of manufacturing...
4 years agoThe Importance of Efficacy in COVID-19 Vaccines
With a number of competing vaccines rapidly rolling out around the world, for many COVID-19 seems an already receding issue. The leading vaccines - from AstraZeneca/University of Oxford, from Pfizer and from Moderna - are in the process of manufacturing...
4 years ago
Weekly News Round-up – 15/1/21
In the news this week, COVID vaccine production continues to advance, with Regeneron signing a new $2.6 billion deal in the US, the J&J one-shot looks set to distribute in March 2021, and two inhaler treatments advance in trials. In...
4 years agoWeekly News Round-up – 15/1/21
In the news this week, COVID vaccine production continues to advance, with Regeneron signing a new $2.6 billion deal in the US, the J&J one-shot looks set to distribute in March 2021, and two inhaler treatments advance in trials. In...
4 years ago
Weekly News Round-up – 8/1/21
Vaccines dominate the news this week, as multiple companies come ever closer to having their products greenlit for market. Janssen’s single-shot vaccine could be approved within weeks, while Moderna’s vaccine sees EU take-up and AZ/Oxford University’s product seems set for...
4 years agoWeekly News Round-up – 8/1/21
Vaccines dominate the news this week, as multiple companies come ever closer to having their products greenlit for market. Janssen’s single-shot vaccine could be approved within weeks, while Moderna’s vaccine sees EU take-up and AZ/Oxford University’s product seems set for...
4 years ago